Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy.,The Journal of Urology

当前位置： X-MOL 学术 › J. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
The Journal of Urology ( IF 6.6 ) Pub Date : 2024-04-11 , DOI: 10.1097/ju.0000000000003965
Marie-Pier St-Laurent ₁ , George Acland ₂ , Sarah N. Hamilton _{3,

4} , Jeremy Hamm ₅ , Katherine Sunderland ₅ , Peter C. Black ₁ , Michael McKenzie _{3,

4} , Mira Keyes _{3,

4} , Stacy Miller ₆ , Martin E. Gleave ₁ , Scott Tyldesley _{3,

4}

Affiliation

Second malignancy is a rare but potentially lethal event after prostate brachytherapy, but data remain scarce on its long-term risk. The objective of this study is to estimate the number of pelvic second malignancies following brachytherapy compared to prostatectomy (RP).

中文翻译：